Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Plastics in dialysis: could they add toxins to Children's blood?

NCT ID NCT07763483

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 18, 2026 · Updated 3 times

Summary

This study looks at whether children with chronic kidney disease, especially those on dialysis, have higher levels of PFAS chemicals in their blood. PFAS are found in many everyday products and may interfere with bone development. The study compares PFAS levels in children with kidney disease who are not on dialysis, those on peritoneal dialysis, and those on hemodialysis. It also checks if PFAS levels change during a hemodialysis session. The goal is to see if dialysis equipment, which contains plastics, might contribute to PFAS exposure in children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood sample collection for PFAS measurement
What this could lead to
If this pilot shows that dialysis affects PFAS levels in children, it could lead to larger studies and eventually strategies to reduce exposure and protect bone health in young dialysis patients.
What could go wrong
This is a small pilot study with only 15 participants, so results may not apply broadly. It only measures PFAS levels, not direct health outcomes, and cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from the Pediatric Nephrology Department of the Femme-Mère-Enfant Hospital, Hospices Civils de Lyon. A total of 15 patients will be enrolled in the study, distributed as follows: * 3 children with non-dialysis chronic kidney disease (CKD) stages 1-2 * 3 children with non-dialysis chronic kidney disease (CKD) stages 4-5 * 3 children receiving peritoneal dialysis * 3 children receiving paediatric haemodialysis with pre-dilution hemodiafiltration * 3 children receiving paediatric haemodialysis with post-dilution hemodiafiltration.

Ages

2 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 0 to 17 years (inclusive), followed in the Paediatric Nephrology Department of the Femme-Mère-Enfant Hospital, Hospices Civils de Lyon. * No objection from the parents or legal guardian(s). * Assent of the minor participant, when appropriate according to age and level of understanding * For group 1: Children with non-dialysis chronic kidney disease (CKD) stages 1-2, weighing at least 5 kg. * For group 2: Children with non-dialysis chronic kidney disease (CKD) stages 4-5, weighing at least 5 kg. * For group 3: Children receiving peritoneal dialysis, weighing at least 5 kg. * For group 4: Children receiving paediatric haemodialysis with pre-dilution hemodiafiltration, weighing at least 12 kg. * For group 5: Children receiving paediatric haemodialysis with post-dilution hemodiafiltration, weighing at least 12 kg. Exclusion Criteria: * Participation in another interventional research study with an exclusion period still ongoing on the day of inclusion and deemed by the investigator to potentially interfere with the present study. * Individuals deprived of liberty by a judicial or administrative decision.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease (CKD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease (CKD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Femme-Mère-Enfant

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.